M
Matejka Rebolj
Researcher at King's College London
Publications - 107
Citations - 6507
Matejka Rebolj is an academic researcher from King's College London. The author has contributed to research in topics: Cervical cancer & Cervical screening. The author has an hindex of 28, co-authored 95 publications receiving 5494 citations. Previous affiliations of Matejka Rebolj include Copenhagen University Hospital & Queen Mary University of London.
Papers
More filters
Journal ArticleDOI
The Danish National Patient Register
TL;DR: Although the NPR is overall a sound data source, both the content and the definitions of single variables have changed over time and researchers using the data should carefully consider potential fallacies in the data before drawing conclusions.
Journal ArticleDOI
Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study
Joakim Dillner,Matejka Rebolj,Philippe Birembaut,Karl Ulrich Petry,Anne Szarewski,Christian Munk,Silvia de Sanjosé,Pontus Naucler,Belen Lloveras,Susanne K. Kjaer,Jack Cuzick,Marjolein van Ballegooijen,Christine Clavel,Thomas Iftner +13 more
TL;DR: A consistently low six year cumulative incidence rate of CIN3+ among women negative for HPV suggests that cervical screening strategies in which women are screened for HPV every six years are safe and effective.
Journal ArticleDOI
Cervical cancer screening policies and coverage in Europe
Ahti Anttila,Lawrence von Karsa,Auni Aasmaa,Murielle Fender,Julietta Patnick,Matejka Rebolj,Florian A. Nicula,Laszlo Vass,Zdravka Valerianova,Lydia Voti,Catherine Sauvaget,Guglielmo Ronco +11 more
TL;DR: It is indicated that, despite substantial efforts, the recommendations of the Council of the EU on organised population-based screening for cervical cancer are not yet fulfilled and decision-makers and health service providers should consider stronger measures or incentives in order to improve cervical cancer control in Europe.
Journal ArticleDOI
The challenges of organising cervical screening programmes in the 15 old member states of the European Union.
Marc Arbyn,Matejka Rebolj,Matejka Rebolj,Inge M.C.M. de Kok,Murielle Fender,Nikolaus Becker,Marian O’Reilly,Bengt Andrae +7 more
TL;DR: Introduction of new methods of prevention, such as HPV screening and prophylactic HPV vaccination, can reduce the burden further, but this will require a high level of organisation with particular attention needed for the maximisation of population coverage.
Journal ArticleDOI
Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands.
TL;DR: The 1996 changes in protocols and guidelines, and their implementation have increased coverage and efficiency, and decreased the screening‐induced negative side effects.